文献
J-GLOBAL ID：201102210905143195
整理番号：11A0769144 自然免疫および獲得免疫によるヒトT細胞白血病ウイルス1型の二重制御システム
Double control systems for human T-cell leukemia virus type 1 by innate and acquired immunity
- 出版者サイト 複写サービスで全文入手
- 高度な検索・分析はJDreamⅢで
引用文献 (79件)
- HINUMA, Y. Adult T-cell leukemia : antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA. 1981, 78, 6476-6480
- POIESZ, BJ. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA. 1980, 77, 7415-7419
- TAJIMA, K. The 4th nation-wide study of adult T-cell leukemia/lymphoma (ATL) in Japan : estimates of risk of ATL and its geographical and clinical features. The T- and B-cell Malignancy Study Group. Int J Cancer. 1990, 45, 237-243
- UCHIYAMA, T. Human T cell leukemia virus type I (HTLV-I) and human diseases. Annu Rev Immunol. 1997, 15, 15-37
- OSAME, M. HTLV-I associated myelopathy, a new clinical entity. Lancet. 1986, 1, 1031-1032
- GESSAIN, A. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet. 1985, 2, 407-410
- MOCHIZUKI, M. Uveitis associated with human T-cell lymphotropic virus type I. Am J Ophthalmol. 1992, 114, 123-129
- NISHIOKA, K. Chronic inflammatory arthropathy associated with HTLV-I. Lancet. 1989, 1, 441
- UTSUNOMIYA, A. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001, 27, 15-20
- OKAMURA, J. Allogeneic stem-cell transplantation with reduced conditioning intensity as a novel immunotherapy and antiviral therapy for adult T-cell leukemia/lymphoma. Blood. 2005, 105, 4143-4145
- YAMAMOTO, K. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. J Clin Oncol. 2010, 28, 1591-1598
- HERMINE, O. A prospective phase II clinical trial with the use of zidovudine and interferon-alpha in the acute and lymphoma forms of adult T-cell leukemia/lymphoma. Hematol J. 2002, 3, 276-282
- YOSHIDA, M. Multiple viral strategies of HTLV-1 for dysregulation of cell growth control. Annu Rev Immunol. 2001, 19, 475-496
- GRASSMANN, R. Molecular mechanisms of cellular transformation by HTLV-1 Tax. Oncogene. 2005, 24, 5976-5985
- JEANG, KT. Life, death, and tax : role of HTLV-I oncoprotein in genetic instability and cellular transformation. J Biol Chem. 2004, 279, 31991-31994
- MATSUOKA, M. Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation. Nat Rev Cancer. 2007, 7, 270-280
- KANNAGI, M. Specific cytolysis of fresh tumor cells by an autologous killer T cell line derived from an adult T cell leukemia/lymphoma patient. J Immunol. 1984, 133, 1037-1041
- JACOBSON, S. Circulating CD8+ cytotoxic T lymphocytes specific for HTLV-I pX in patients with HTLV-I associated neurological disease. Nature. 1990, 348, 245-248
- ARNULF, B. Loss of the ex vivo but not the reinducible CD8+ T-cell response to Tax in human T-cell leukemia virus type 1-infected patients with adult T-cell leukemia/lymphoma. Leukemia. 2004, 18, 126-132
- KATO, H. Oral administration of human T-cell leukemia virus type 1 induces immune unresponsiveness with persistent infection in adult rats. J Virol. 1998, 72, 7289-7293
前のページに戻る
